ClinicalTrials.Veeva

Menu

Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge

T

Taiwan Carbon Nano Technology

Status

Enrolling

Conditions

Vaginitis
Vaginal Infection

Treatments

Device: Metabolic gas signatures detected by Ainos Flora (operated by participant)
Device: Metabolic gas signatures detected by Ainos Flora (operated by medical staff)
Device: Vaginal swab for RT-PCR
Device: Vaginal swab for culture

Study type

Interventional

Funder types

Industry

Identifiers

NCT05557318
A202203003

Details and patient eligibility

About

This clinical study aims to train the algorithm and assess the performance of the Ainos Flora Women's Vaginal Health Tester in identifying vaginal infections.

Full description

Ainos Flora Women's Vaginal Health Tester is an in vitro diagnostic device implementing electronic nose technology to detect vaginal infections by examining metabolized gases of vaginal bacteria. The electronic nose system mainly comprises the Micro-Electro-Mechanical Systems (MEMS) gas sensor array and the Artificial Neural Network algorithm. The primary purpose of this study is to train the algorithm and assess the performance of the Ainos Flora in identifying vaginal infections. In addition, the primary outcome measures of this study, including sensitivity and specificity, will be used as a reference for the feasibility and sample size assessment of the next phase of pivotal clinical trials.

Enrollment

120 estimated patients

Sex

Female

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female, Age ≥20 to ≤50.
  • Have had sexual experience.
  • Fully understand the subject's informed consent process and be willing to undergo all study-related assessments and procedures.

Exclusion criteria

Women who meet any of the following criteria by participant report will be excluded from the study:

  • During menstruation.
  • Have performed vaginal washing within three days.
  • Have been treated for vaginal infections within one week.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 4 patient groups

Bacterial infections
Experimental group
Description:
The subject is infected with at least one of the following pathogens: Bacterial vaginosis (BV) / Escherichia coli / Trichomonas / Group B streptococcus / Chlamydia trachomatis / Neisseria gonorrhoeae
Treatment:
Device: Metabolic gas signatures detected by Ainos Flora (operated by medical staff)
Device: Vaginal swab for culture
Device: Vaginal swab for RT-PCR
Device: Metabolic gas signatures detected by Ainos Flora (operated by participant)
Fungal infection :
Experimental group
Description:
The subject is infected with Candida albicans only.
Treatment:
Device: Metabolic gas signatures detected by Ainos Flora (operated by medical staff)
Device: Vaginal swab for culture
Device: Vaginal swab for RT-PCR
Device: Metabolic gas signatures detected by Ainos Flora (operated by participant)
Mixed infection
Experimental group
Description:
Bacterial and fungal infections coexist.
Treatment:
Device: Metabolic gas signatures detected by Ainos Flora (operated by medical staff)
Device: Vaginal swab for culture
Device: Vaginal swab for RT-PCR
Device: Metabolic gas signatures detected by Ainos Flora (operated by participant)
No infection
Experimental group
Description:
Healthy participant
Treatment:
Device: Metabolic gas signatures detected by Ainos Flora (operated by medical staff)
Device: Vaginal swab for culture
Device: Vaginal swab for RT-PCR
Device: Metabolic gas signatures detected by Ainos Flora (operated by participant)

Trial contacts and locations

2

Loading...

Central trial contact

Dr. Fung-Wei Chang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems